CRDF
Cardiff Oncology Inc
Price:  
3.70 
USD
Volume:  
7,427,891.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Cardiff WACC - Weighted Average Cost of Capital

The WACC of Cardiff Oncology Inc (CRDF) is 6.5%.

The Cost of Equity of Cardiff Oncology Inc (CRDF) is 9.40%.
The Cost of Debt of Cardiff Oncology Inc (CRDF) is 5.00%.

Range Selected
Cost of equity 7.90% - 10.90% 9.40%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 5.00% - 5.00% 5.00%
WACC 5.8% - 7.3% 6.5%
WACC

Cardiff WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.87 1.08
Additional risk adjustments 0.0% 0.5%
Cost of equity 7.90% 10.90%
Tax rate 26.20% 27.00%
Debt/Equity ratio 1 1
Cost of debt 5.00% 5.00%
After-tax WACC 5.8% 7.3%
Selected WACC 6.5%